Scorpion Venom Drug Biz Hit With SEC Fraud Suit
By Renee Hickman ( May 15, 2023, 7:39 PM EDT) -- The U.S. Securities and Exchange Commission on Monday hit biopharmaceutical company Quanta and its CEO and executive vice president with a suit accusing the company of financial fraud over a 2021 press release the agency says misrepresented the U.S. Food and Drug Administration's response to a proposed clinical trial of the drug Escozine as a COVID-19 treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.